Literature DB >> 28159173

Legionnaire's Disease and Influenza.

Eleni E Magira1, Sryros Zakynthinos2.   

Abstract

Legionella pneumophila and influenza types A and B viruses can cause either community-acquired pneumonia with respiratory failure, or Legionella infection could attribute to influenza infection with potentially fatal prognosis. Copathogenesis between pandemic influenza and bacteria is characterized by complex interactions between coinfecting pathogens and the host. Understanding the underlying reason of the emersion of the secondary bacterial infection during an influenza infection is challenging. The dual infection has an impact on viral control and may delay viral clearance. Effective vaccines and antiviral therapy are crucial to increase resistance toward influenza, decrease the prevalence of influenza, and possibly interrupt the potential secondary bacterial infections.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coinfection; Host; Immunopathogenesis; Influenza; Legionellosis; Secondary infection

Mesh:

Substances:

Year:  2017        PMID: 28159173     DOI: 10.1016/j.idc.2016.10.010

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  3 in total

1.  Legionella pneumonia immediately after recovery from COVID-19.

Authors:  Daisuke Jingu; Hiroshi Takahashi; Satoshi Ubukata; Hiroshi Watanabe; Akira Horii
Journal:  Clin Case Rep       Date:  2022-07-19

Review 2.  Legionella Pneumophila and Dendrimers-Mediated Antisense Therapy.

Authors:  Roghiyeh Pashaei-Asl; Khodadad Khodadadi; Fatima Pashaei-Asl; Gholamreza Haqshenas; Nasser Ahmadian; Maryam Pashaiasl; Reza Hajihosseini Baghdadabadi
Journal:  Adv Pharm Bull       Date:  2017-06-30

Review 3.  SARS-CoV-2-Legionella Co-Infections: A Systematic Review and Meta-Analysis (2020-2021).

Authors:  Matteo Riccò; Pietro Ferraro; Simona Peruzzi; Alessandro Zaniboni; Silvia Ranzieri
Journal:  Microorganisms       Date:  2022-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.